Andrew J. Last
Independent DirectorDr. Andrew J. Last, also known as Andy, Ph.D., served as Executive Vice President & Chief Operating Officer of Bio-Rad Laboratories, Inc. since April 22, 2019 until September 09, 2024. Dr. Last has been an Independent Director of Insight Molecular Diagnostics Inc. (formerly known as OncoCyte Corporation) since December 2015. He serves as an Independent Director of CellChorus Inc. In January of 2018, Dr. Last served as Chief Commercial Officer at Berkeley Lights. Dr. Last served as the Chief Operating Officer of Intrexon Corporation from August 29, 2016 to November 27, 2017. Dr. Last served as the Chief Operating Officer of Affymetrix Inc. from January 9, 2014 to March 31, 2016 and its Executive Vice President from 2010 to March 31, 2016. He served as an Executive Vice President of Genetic Analysis and Clinical Applications Business Unit for Affymetrix Inc. until January 9, 2014. He served as the Chief Commercial Officer and Executive Vice President of Affymetrix Inc., since December 2009. Prior to joining Affymetrix, Dr. Last served on the leadership team of BD Biosciences Cell Analysis Unit, where he served as Vice President of Global Marketing & Strategic Planning and General Manager of the San Diego-based Pharmingen Business from 2004 to 2010. He has held senior management positions at Monsanto, Incyte Genomics and Becton Dickinson. From 2002 to 2004, he held management positions at Applied Biosystems, Inc., including as Vice President and General Manager from 2003 to 2004 and Vice President of Marking from 2002 to 2003. He holds a Ph. D. and MS degrees with specialization in Agrochemical Chemicals and Bio-Aeronautics, respectively, from Cranfield University and a BS degree in Biological Sciences from the University of Leicester in the United Kingdom.
公司職務
- 公司名稱Insight Molecular Diagnostics Inc.股票代碼IMDX職務Independent Director共事同僚
- JRJoshua RiggsPresident, CEO & Director
- AAAndrew ArnoIndependent Chairman
- ASAndrea Susan JamesChief Financial Officer
- JLJames LiuVP of Accounting, Treasurer, Controller & Principal Accounting Officer
- YCYuh-Min ChiangChief Technology Officer
- ESEkkehard SchutzChief Science Officer
- LELouis E. SilvermanIndependent Director
- DRDavid R. GandaraMember of Scientific & Medical Advisory Board
